Revvity Inc
RVTY96.200USD
-0.060-0.06%
종가 12/19, 16:00（ET）시세는 15분 지연됩니다
10.97B시가총액
48.35P/E TTM
자세한 내용은 Revvity Inc 회사
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Revvity Inc 정보
종목 코드 RVTY
회사 이름Revvity Inc
상장일Aug 12, 2101
CEOSingh (Prahlad R)
직원 수11000
유형Ordinary Share
회계 연도 종료Aug 12
주소77 4Th Avenue
도시WALTHAM
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호02451
전화17816636900
웹사이트https://www.revvity.com/
종목 코드 RVTY
상장일Aug 12, 2101
CEOSingh (Prahlad R)
Revvity Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-53.85%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Product
610.70M
84.79%
Service
109.58M
15.21%
지역별USD
이름
수익
비율
Americas
323.58M
44.92%
Europe
203.63M
28.27%
Asia
193.07M
26.80%
사업별
지역별
사업별USD
이름
수익
비율
Product
610.70M
84.79%
Service
109.58M
15.21%
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
기타
46.93%
주주
주주
비율
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
기타
46.93%
주주 유형
주주
비율
Investment Advisor
70.04%
Investment Advisor/Hedge Fund
25.98%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
T. Rowe Price Investment Management, Inc.
22.64M
19.51%
+126.19K
+0.56%
Jun 30, 2025
The Vanguard Group, Inc.
14.03M
12.09%
-297.65K
-2.08%
Jun 30, 2025
EdgePoint Investment Group Inc.
6.79M
5.85%
+1.43M
+26.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.80M
6.72%
-1.59M
-16.90%
Jun 30, 2025
Janus Henderson Investors
7.22M
6.22%
+1.23M
+20.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.81M
5%
-259.62K
-4.28%
Jun 30, 2025
State Street Investment Management (US)
5.02M
4.32%
-150.58K
-2.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.98M
2.56%
-18.52K
-0.62%
Jun 30, 2025
Invesco Capital Management LLC
1.94M
1.67%
+422.41K
+27.88%
Jun 30, 2025
UBS Financial Services, Inc.
1.75M
1.51%
+1.12M
+178.25%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
더 보기
First Trust Indxx Medical Devices ETF
비율2.12%
Invesco S&P 500 Equal Weight Health Care ETF
비율1.85%
T Rowe Price Capital Appreciation Equity ETF
비율1.36%
Simplify Health Care ETF
비율1.29%
ROBO Global Healthcare Technology & Innovation ETF
비율1.16%
First Trust Health Care Alphadex Fund
비율0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
비율0.84%
VanEck Morningstar SMID Moat ETF
비율0.64%
Neuberger Berman Small-Mid Cap ETF
비율0.56%
NYLI Candriam US Mid Cap Equity ETF
비율0.5%
주식 배당금
지난 5년 동안 총
168.35M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Revvity Inc의 상위 5대 주주는 누구인가요?
Revvity Inc의 상위 5대 주주는 다음과 같습니다:
T. Rowe Price Investment Management, Inc.는 22.64M주의 주식을 보유하고 있으며, 전체 주식의 19.51%를 차지합니다.
The Vanguard Group, Inc.는 14.03M주의 주식을 보유하고 있으며, 전체 주식의 12.09%를 차지합니다.
EdgePoint Investment Group Inc.는 6.79M주의 주식을 보유하고 있으며, 전체 주식의 5.85%를 차지합니다.
T. Rowe Price Associates, Inc.는 7.80M주의 주식을 보유하고 있으며, 전체 주식의 6.72%를 차지합니다.
Janus Henderson Investors는 7.22M주의 주식을 보유하고 있으며, 전체 주식의 6.22%를 차지합니다.
T. Rowe Price Investment Management, Inc.는 22.64M주의 주식을 보유하고 있으며, 전체 주식의 19.51%를 차지합니다.
The Vanguard Group, Inc.는 14.03M주의 주식을 보유하고 있으며, 전체 주식의 12.09%를 차지합니다.
EdgePoint Investment Group Inc.는 6.79M주의 주식을 보유하고 있으며, 전체 주식의 5.85%를 차지합니다.
T. Rowe Price Associates, Inc.는 7.80M주의 주식을 보유하고 있으며, 전체 주식의 6.72%를 차지합니다.
Janus Henderson Investors는 7.22M주의 주식을 보유하고 있으며, 전체 주식의 6.22%를 차지합니다.
Revvity Inc의 상위 3대 주주 유형은 무엇인가요?
Revvity Inc의 주요 주주 유형 상위 3가지는
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.입니다.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.입니다.
Revvity Inc(RVTY)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Revvity Inc의 주식을 보유한 기관은 총 1177곳이며, 이들이 보유한 주식의 총 가치는 약 117.06M로 전체 발행 주식의 100.85%를 차지합니다. 이는 2025Q2 대비 2.82% 증가한 수치입니다.
Revvity Inc의 최대 수익원은 무엇인가요?
FY2025Q2 기준, Revvity Inc의 Product 부문이 가장 높은 매출을 기록했으며, 금액은 610.70M로 전체 매출의 84.79%를 차지했습니다.
